ConditionSkin, hair & nails
Epidermodysplasia Verruciformis (EV)
Epidermodysplasia verruciformis (EV) is a rare inherited skin condition in which the immune system cannot control certain types of human papillomavirus (HPV) in the skin. People develop many flat, wart-like lesions and scaly, discolored patches, starting in childhood. Over time, up to half develop skin cancer, mainly squamous cell carcinoma on sun-exposed skin. There is no cure, but strict sun protection, regular skin checks and early removal of suspicious lesions are essential.
Also called: EV, Lewandowsky-Lutz dysplasia, tree man syndrome (in severe cases)
At a glance
- What it is
- An inherited susceptibility to widespread skin infection with certain HPV types.
- Genetics
- Usually autosomal recessive, most often from TMC6, TMC8 or CIB1 gene variants.
- Signs
- Flat, wart-like papules and pink, red-brown or pale scaly patches, from childhood.
- Main risk
- Skin cancer, especially squamous cell carcinoma, from the 20s to 40s onward.
- Care
- Lifelong sun protection, regular dermatology checks, removal of precancerous and cancerous lesions.
When to get help
See a doctor within a day or two
- A lesion that grows quickly, bleeds, ulcerates or becomes painful
Book a routine appointment
- Many flat warts or scaly patches that keep spreading, especially if they started in childhood
- A new wart-like rash in someone with HIV or after an organ transplant
- Overdue skin check in someone with EV
Usually safe to manage at home
- A few flat warts on the face or hands in a healthy child, which often clear on their own
What causes EV
Everyone is exposed to many types of HPV. Certain "beta-HPV" types (especially HPV-5 and HPV-8) are normally harmless and kept in check by the skin's immune defenses. In classic EV, inherited changes in genes such as TMC6 (EVER1), TMC8 (EVER2) or CIB1 disrupt this control in skin cells, so these viruses spread widely in the skin.
The condition is usually autosomal recessive: a child inherits one faulty copy from each parent, who are typically healthy carriers. It is more common where parents are related. It is not contagious in the usual sense; the HPV types are everywhere, and the problem is the person's inability to control them.
Acquired EV
A similar condition can develop in people with weakened immune systems: HIV, organ transplant recipients on immune-suppressing drugs, and some other immune disorders. It is called acquired EV.
Signs and symptoms
- flat, wart-like papules similar to flat warts, on the face, hands, arms and legs
- scaly patches that are pink, red-brown or lighter than surrounding skin, resembling tinea versicolor or seborrheic keratoses, often on the trunk and neck
- lesions start in childhood (often between ages 5 and 11) and increase over years
- in rare severe forms, large horn-like growths develop on the hands and feet ("tree man syndrome")
- actinic keratoses and skin cancers on sun-exposed areas, often beginning in the 20s to 40s
Skin cancer risk
Roughly 30 to 60 percent of people with classic EV develop skin cancer during their lifetime. Most are squamous cell carcinomas in situ or invasive, mainly on the forehead, face and other sun-exposed skin. Ultraviolet light and the HPV types work together to cause these cancers. They tend to grow slowly but can become invasive and, rarely, spread.
Diagnosis
- clinical appearance of widespread flat warts and scaly patches from childhood
- skin biopsy: shows typical "EV cells", enlarged cells with bluish-gray pale cytoplasm in the upper layers of the skin
- HPV testing of skin samples
- genetic testing for TMC6, TMC8, CIB1 and other genes
- immune testing and HIV testing if acquired EV is suspected
Treatment
There is no cure. Care focuses on preventing and treating skin cancer and improving the appearance of lesions.
Sun protection
The most important measure, starting in childhood:
- broad-spectrum sunscreen SPF 30 or higher daily
- protective clothing, hats and sunglasses
- avoiding midday sun and tanning beds
Treating lesions
- topical treatments: retinoids, imiquimod, 5-fluorouracil
- cryotherapy (freezing) and curettage
- photodynamic therapy for precancerous changes
- oral retinoids (acitretin) to reduce new lesions and cancers in some patients
- surgery, including Mohs surgery, for skin cancers
- surgical debulking for the large horn-like growths in severe forms
Lesions often return after treatment because the underlying susceptibility persists.
Acquired EV
Improving immune function, for example with HIV treatment or adjusting transplant medicines, may help lesions improve.
Monitoring
- full skin checks by a dermatologist every 3 to 6 months, or as advised
- prompt biopsy of any changing lesion
- genetic counseling for families
Outlook
People with EV have a normal lifespan when skin cancers are caught and treated early. The condition is lifelong, and the burden of lesions and procedures can be significant, so psychological support helps.
Frequently asked questions
What is epidermodysplasia verruciformis?
It is a rare inherited skin condition in which certain HPV types grow widely in the skin, causing many flat, wart-like spots and scaly patches from childhood. People with EV have a high risk of skin cancer, especially on sun-exposed skin.
Is epidermodysplasia verruciformis contagious?
Not in the usual sense. The HPV types involved are common and harmless for most people. People with EV have an inherited or acquired weakness in controlling them, so others who come into contact do not develop EV.
What is tree man syndrome?
"Tree man syndrome" is a popular name for severe EV in which large, bark-like horny growths develop on the hands and feet. It is extremely rare. Surgical removal can improve function, but growths often recur.
Can epidermodysplasia verruciformis be cured?
No. The inherited susceptibility is lifelong. Treatments can remove or reduce lesions and catch skin cancers early, and sun protection lowers cancer risk. In acquired EV, improving immune function may help lesions regress.
How is skin cancer prevented in EV?
Strict sun protection from childhood is key, along with regular dermatology checks, early treatment of precancerous lesions, and sometimes oral retinoids. Any growing, bleeding or changing lesion should be biopsied promptly.
Sources
This guide was written from current patient and clinical guidance, including:
- National Organization for Rare Disorders (NORD): Epidermodysplasia Verruciformis
- MedlinePlus Genetics: Epidermodysplasia verruciformis
- DermNet: Epidermodysplasia verruciformis
- American Academy of Dermatology: Warts - Overview
- Genetic and Rare Diseases Information Center (GARD): Epidermodysplasia verruciformis